TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast CancerSteven J. Isakoff, Leif W. Ellisen, Lisa A. Carey et al.|Journal of Clinical Oncology|2015Cited by 433
TBCRC009: A multicenter phase II study of cisplatin or carboplatin for metastatic triple-negative breast cancer and evaluation of p63/p73 as a biomarker of response.SJ Isakoff, Leif W. Ellisen, Paul E. Goss et al.|Journal of Clinical Oncology|2011Cited by 35